Introduction
For several years Britain's relatively poor performance in providing long term treatment for renal failure has been highlighted in the annual statistical reports of the European Dialysis and Transplant Association' and has been a contentious issue in both the medical press and public news media. Fortunately, the need to do better has now received political recognition, and a national annual target for the treatment of new patients has been set. The figure chosen for England (40/year/million population by 1987)2 is modest by European comparisons but at least represents a move in the right direction.
The number of people being treated is increasing, but the treatment itself is changing: continuous ambulatory peritoneal dialysis (CAPD) in particular has proved popular in British renal units. At the end of 1983, 28% of all British dialysis patients were receiving CAPD, and a quarter of the patients receiving peritoneal dialysis in Europe were being treated in the United Kingdom compared with only 6% of the haemodialysis patients.' The long term outlook for patients receiving CAPD is still relatively unclear, and the implications of its widespread use in Britain need examination. We therefore reviewed the experience of CAPD and its effect on the pattern of work of the Nottingham renal unit over the past six years.
Methods
The renal unit at the City Hospital, Nottingham, provides all the treatment for end stage Although minor variations in CAPD methods and systems occurred during the time of the survey, most patients were treated with Travenol products with the "spike" system until 1983 and the "Luer lock" system since then. Double cuff Silastic Tenckhoff catheters were inserted in the midline with an introducer under local anaesthetic in all patients who had not had previous abdominal surgery. General anaesthesia and placement under direct vision were used for patients with abdominal scars and for repositioning malfunctioning catheters.
Results
In six years 229 patients with end stage renal failure began renal replacement treatment in Nottingham. In the same period 150 patients (84 men and 66 women) aged from 11 to 73 (median 52) started receiving CAPD, most as a first treatment or after only a short period of haemodialysis. To begin with CAPD was used mainly for patients who had encountered problems with haemodialysis, but this policy quickly changed and patient preference became the main determinant of choice of treatment. Only two patients had two separate periods of CAPD-that is, CAPD was interrupted by another form of treatment for more than three months-and the second periods of treatment were excluded from analysis.
At three years actuarial survival of patients who received CAPD was 69% and the success of the technique was 41% (fig 1) . Twenty three patients died while receiving CAPD, the main causes being infection related to dialysis (eight patients), other infection (seven), cardiovascular problems (four), or other reasons (four). At the end of the survey 22 patients who had received renal replacement treatment for more than three years were alive; 10 were still receiving CAPD.
In occurrence that was as common in the first 75 patients (five deaths) of the series as in the rest and that was associated with periods of CAPD lasting a median of four (range one to 18) months. In three patients multiple problems led to withdrawal of active treatment, in two others malnutrition during CAPD complications seemed to have contributed to death, but in the remainder the cause of death was not thought to have been directly related to the type of renal replacement treatment.
The rate of acceptance of new patients increased during the survey (table) , averaging 32 patients a year in the first three years and 44 patients a year subsequently. CAPD was used as a first treatment not only in an increasing number of patients but also in a higher proportion (81 of 132; 61%) in the last three years. Figure 2 shows how the constitution of the dialysis population in Nottingham changed considerably with the introduction of CAPD. The number of patients receiving CAPD increased particularly rapidly after 1982, while the number receiving haemodialysis changed relatively little. Within the haemodialysis group the proportion receiving regular treatment in the hospital unit tended to increase during the last two years, a change largely attributable to the increasing number of patients in whom CAPD failed and who received hospital haemodialysis. The median age of new patients receiving any form of dialysis increased from 44 in the three years before CAPD was introduced to 47 in the first half of the study and 52 in the second half.
Discussion
The six years covered by this survey have seen considerable change in the provision of renal replacement treatment in Nottingham: 28 new patients were treated in the first year compared with 43 in the last, and the population of patients receiving dialysis increased from 33 to 132. What has been responsible for the expansion in the provision of renal replacement treatment? In the first or second year of the survey relatively more patients may have been considered to be unsuitable for dialysis, but this can have had only a small effect, and the policy of patient acceptance has generally been liberal. The main change has been an increase in the referral of new cases, and the availability of CAPD has, we think, been one of the factors that has brought this about. The arrival of a new technique has acted as a talking point both nationally and locally and has drawn new attention to the possibility of renal replacement treatment. The assertion that older patients adapt particularly well to CAPD3 seems to have been relevant and to have corrected the element of negative selection4 that previously operated to the detriment of this group. We too find that older patients take to CAPD easily, but in many cases we can treat them just as well with haemodialysis, and it is ironic that they might not have been sent for treatment of any sort before CAPD became available.
The most worrying point that emerges from this analysis is the relatively low long term success of CAPD in the individual patient. There is as yet only limited information on the continued use of CAPD in patients based on follow up of more than two years,' but the 56% at two years observed here seems typical and the 41% at three years consistent with projections from published data.69 Recurrent peritoneal infection is the main cause of CAPD being stopped, and our series is no exception. Some patients earn the reputation of being good patients whose meticulous attention to technique (and perhaps inherent resistance to infection) renders them at low risk of peritonitis, but regrettably the shape of the technique survival curve does not support this clinical observation. The interval risk is much the same at six months as at three years, suggesting that low risk patients still receiving treatment after this time are not different from others but have merely been lucky, and that there is no subgroup that can look forward to indefinite peritoneal dialysis.
The relatively short term success of CAPD is illustrated by the fate of those patients who changed from CAPD to haemodialysis. A disturbingly high number died within a few months of the change, but it is difficult to know whether the failure of CAPD increased the risk of dying, as it could be argued that such patients would have done badly with any form of treatment. Nevertheless, changing treatment is likely to introduce new hazards, and the 64% survival one year after change compares unfavourably not only with the 89% annual survival (fig 1) of patients continuing to receive CAPD but even with the fate ofhigh risk diabetics receiving haemodialysis.'0 A similar phenomenon has been seen in the statistics of the European Dialysis and Transplant Association,'" and in some of our patients the delayed effects ofCAPD complications were thought at the time to have contributed to death. Not surprisingly, such patients were usually receiving hospital haemodialysis at the time of death, though hospital haemodialysis was also the most likely treatment for patients who survived the period after CAPD failure. The fact that such patients are often elderly, have other medical problems apart from end stage renal failure, and lack appropriate home support make home haemodialysis and transplantation unsuitable alternatives. Our experience has not borne out the prediction from early experience of CAPD in the elderly that transfer to hospital haemodialysis would be uncommon.3
The disappointing long term success of CAPD" should not detract from its usefulness as first treatment. The opportunity to teach patients how to treat themselves and to return them home rehabilitated and independent (often within two weeks) is very valuable, and the quality of life that CAPD allows is generally most acceptable. Elective transplantation from CAPD is satisfactory in both our own experience and that of others,'2 13 but the possibility that abandoning CAPD in favour ofhaemodialysis introduces some risk means that a decision to offer CAPD as a first treatment to most patients needs to be taken with care. We now favour CAPD in younger patients for whom an early transplant is planned as definitive treatment but prefer home haemodialysis for older patients when domestic and other factors are favourable and the risk of transplantation is considered too great. In frail elderly patients unsuitable for home haemodialysis it may be better to opt for hospital based haemodialysis from the start.
One particular consequence of the widespread use of CAPD can be foreseen. Unless there is a big reduction in the incidence of peritonitis or an increase in the effectiveness of its treatment most patients beginning renal replacement treatment with CAPD will require an alternative treatment within a few years. For many this will be hospital haemodialysis. In Britain, in contrast with most other European countries,' only a small proportion of dialysis patients receive their treatment in a hospital unit, but an alteration to this pattern should be anticipated. Our haemodialysis units will progressively -accumulate elderly patients, often with multiple medical problems and requiring substantial social service support. Many units will lack the facilities to support a large population of hospital based patients and will thus require additional funding to permit expansion. This should not be seen as an unfortunate burden on the National Health Service but as the consequence of our country's perfectly proper decision to ensure that renal replacement treatment is available to all those who can benefit from it. A 45 year old woman has a six year history of oedema of the eyelids and surrounding tissues including, occasionally, chemosis of the lower conjunctiva. The condition has not been helped by antiallergy treatment (topical orsystemic) but is helped by diuretics. What treatment is advised?
There are many possible causes of oedema of the eyelids and conjunctivae. The antiallergy treatment is not specified but presumably this includes topical steroids and disodium chromoglycate. In the absence of oedema elsewhere or other systemic causes such as the nephrotic syndrome, localised oedema of the eyelids may result from a deficiency in the elastic tissue of the eyelids, known as blepharochalasis.
I I This condition occurs at different ages and there may be an autosomal dominant inheritance. It has been described both in childhood and in adult life, being characterised by recurrent attacks of oedema of the eyelids over a period of months-or years. There may be associated thickening of the eyelids themselves with telangiectasia. In Ascher's syndrome there may be associated enlargement-of the upper lip together with inflammatory changes in the salivary glands.3 Surgical treatment has been used but the condition may recur. Other local causes to be considered include cellulitis with infection, which would not be relieved to the same extent by diuretics. Trichiniasis would be a possibility if she has lived abroad. Contact dermatitis from plants such as primula or cosmetics can produce oedema of the eyelids but these possibilities would have already been considered with other allergies. Bilateral obstruction of lymphatic drainage by a neoplastic process would be unlikely to have lasted six years without other symptoms.-P K BUXTON, consultant dermatologist, Edinburgh. What is the risk ofcarotid massage in elderly people?
Carotid massage elicits vagal reflexes that slow the heart by acting on the sinoatrial and atrioventricular nodes and lower blood pressure by reducing vasomotor time.' It is used in the diagnosis and treatment of those tachyarrhythmias that respond to vagal effects, and also as a diagnostic test by reproducing the effects of so called carotid sinus hypersensitivity. Risks of carotid massage are generally small, even in old age,2 provided that the procedure is performed with reasonable care. But complications are well recognised. Syncope and fits may occur with compression ofa carotid artery in the presence of contralateral stenosis.3 Hemiplegia and arrhythmic sudden death have been reported.45 Some authorities recommend that carotid massage should not be employed in those aged over 756 or even 60.' Contraindications are not absolu-te but the procedure is potentially hazardous not only in the elderly but also in patients with unstable heart rhythm-for example, someone with myocardial ischaemia or digitalis toxicity. Electrocardiographic monitoring should be used during carotid massage. The indications should be weighed with particular care outside hospital where resuscitation facilities are not usually available.-D A CHAMBERLAIN, COn-
